These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 3808458
1. Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Nordberg A, Winblad B. Neurosci Lett; 1986 Dec 03; 72(1):115-9. PubMed ID: 3808458 [Abstract] [Full Text] [Related]
2. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. Shimohama S, Taniguchi T, Fujiwara M, Kameyama M. J Neurochem; 1986 Jan 03; 46(1):288-93. PubMed ID: 3940287 [Abstract] [Full Text] [Related]
3. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex. Kellar KJ, Whitehouse PJ, Martino-Barrows AM, Marcus K, Price DL. Brain Res; 1987 Dec 08; 436(1):62-8. PubMed ID: 3690354 [Abstract] [Full Text] [Related]
4. Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors? Nilsson L, Adem A, Hardy J, Winblad B, Nordberg A. J Neural Transm; 1987 Dec 08; 70(3-4):357-68. PubMed ID: 3681290 [Abstract] [Full Text] [Related]
5. Muscarinic receptor compensation in hippocampus of Alzheimer patients. Nordberg A, Larsson C, Adolfsson R, Alafuzoff I, Winblad B. J Neural Transm; 1983 Dec 08; 56(1):13-9. PubMed ID: 6133910 [Abstract] [Full Text] [Related]
8. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R. J Neurochem; 1988 Jun 16; 50(6):1914-23. PubMed ID: 3373218 [Abstract] [Full Text] [Related]
9. Topographic distribution of choline acetyltransferase activity and muscarinic and nicotinic receptors in Parkinson brains. Nordberg A, Nyberg P, Windblad B. Neurochem Pathol; 1985 Jun 16; 3(4):223-36. PubMed ID: 3831845 [Abstract] [Full Text] [Related]
10. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease. Lange KW, Wells FR, Jenner P, Marsden CD. J Neurochem; 1993 Jan 16; 60(1):197-203. PubMed ID: 8417140 [Abstract] [Full Text] [Related]
14. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. Aubert I, Cécyre D, Gauthier S, Quirion R. J Comp Neurol; 1996 May 20; 369(1):31-55. PubMed ID: 8723701 [Abstract] [Full Text] [Related]
15. Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics. Hellström-Lindahl E, Winblad B, Nordberg A. Brain Res; 1993 Aug 20; 620(1):42-8. PubMed ID: 8402197 [Abstract] [Full Text] [Related]
17. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Flynn DD, Weinstein DA, Mash DC. Ann Neurol; 1991 Mar 20; 29(3):256-62. PubMed ID: 2042942 [Abstract] [Full Text] [Related]
18. Nicotinic acetylcholine receptors in the rat stomach: I. (-)-[3H]nicotine binding. Nishikawa H, Taniguchi T, Ninomiya H, Fujiwara M. Eur J Pharmacol; 1988 Jan 27; 146(1):97-103. PubMed ID: 3350060 [Abstract] [Full Text] [Related]